Prioritising and optimising multiple medications in elderly multi-morbid patients in general practice

Not Applicable

Completed

• Conditions: Multi-medication in elderly multi-morbid patients; Not Applicable

• Registration Number: ISRCTN99691973
• Lead Sponsor: German Federal Ministry of Education and Research (Bundesministerium Fur Bildung und Forschung [BMBF]) (Germany)

Brief Summary

2016 results in: http://www.ncbi.nlm.nih.gov/pubmed/27456328

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-07-07
• Study Completion: 2009-11-03
• Last Update Posted: 14 January 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients:
1. At least 65 years old, either sex
2. At least three chronic diseases
3. At least five continuous prescriptions
4. At least one practice visit during the last quarter
5. Written informed consent
6. Ability to fill out a questionnaire and participate in a telephone interview

Practices:
1. Practice serves members of the German statutory health insurance system
2. GP practice
3. Physician is specialised in general practice or internal medicine, or without specialisation
4. Internet access
5. Availability of a practice nurse who can participate in the study

Exclusion Criteria

Patients:
1. Life expectancy of less than six months
2. Drug addiction problems
3. Cognitive impairment (Mini Mental State Examination [MMSE] score less than 26)
4. Emotional stress that would prevent participation in the study
5. Participation in a clinical trial within the last 30 days

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. To evaluate practicability: expenditure of time regarding intervention<br> 2. To evaluate feasibility: number of patients who dropped out, reasons for why patients do not participate in study, time expenditure regarding data collection<br> 3. Potential primary outcome for main study: appropriateness of medication (Medication Appropriateness Index [MAI])<br><br> There are three timepoints of data collection in both, the control and the intervention arm:<br> T0: before the beginning of the intervention<br> T1: six weeks after the beginning of the intervention<br> T2: twelve weeks after the beginning of the intervention<br>